TMEM43 and breast cancer: In turn, these patterns of expression were associated with distinct SR depending on subtypes highlighting the significance of each amplicon in defining patient SR for particular BC subtypes (eg 16p13 in lumA and ER+/HER2+, and 8q23-24 in basalL and her2E).